SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
834Yes, it seems that Rick had 100X in mind. Regards the diabetes program, it is Miljenko Zuanic-11/25/2001
833<i> <<10 down, 10 to go. >. 10 + 10, or 10 by 10? </i> MZRCMac-11/23/2001
832<<10 down, 10 to go. >. 10 + 10, or 10 by 10? :)Miljenko Zuanic-11/23/2001
831No complaints here. After our cyclical nuclear winter in biotechs (though we unfLarry Liebman-11/23/2001
830Also a 10-bagger since the wonderful buying opportunity, April to September, 199scaram(o)uche-11/23/2001
829New all-time high, bubble and all. (eom)scaram(o)uche-11/21/2001
828execution, execution, execution........ it's getting boring. :-)scaram(o)uche-11/16/2001
827Friday November 16, 7:00 am Eastern Time Press Release SOURCE: Neurocrine Bioscismh-11/16/2001
826This may be nice *bait* for NBIX. Tuesday November 13, 11:00 am Eastern Time PrMiljenko Zuanic-11/13/2001
825Nice and smart. Don't let greedy bankers and corrupted analysts dictate youMiljenko Zuanic-11/13/2001
824Miljenko, it WOULD make a huge difference. All we need is to have them address Scott H. Davis-11/6/2001
823<<The next fiscal year consensus EPS estimate for this stock has changed fMiljenko Zuanic-11/6/2001
822Consensus EPS per morningstar: NBIX Neurocrine Biosciences The next fismopgcw-11/5/2001
821Thursday November 1, 7:33 am Eastern Time Press Release SOURCE: Neurocrine Bioscaram(o)uche-11/1/2001
820Nice data for SYMPTOMS treatment, not disease itself. MiljenkoMiljenko Zuanic-10/31/2001
819Wednesday October 31, 5:04 pm Eastern Time Press Release SOURCE: Novartis Pharscaram(o)uche-10/31/2001
818Not bad! 15.5 M for delivery of the specific 12 CRFr1 antagonist: "DeliverMiljenko Zuanic-10/29/2001
817Wow - Neurocrine Biosciences Receives First Milestone Payment of $15.5 Million nigel bates-10/29/2001
816Dear Mr. Shorty! *Frigun si ko girica!*Miljenko Zuanic-10/26/2001
815>> And thanks to you Rick << As I've said before, I've justscaram(o)uche-10/26/2001
814Indeed, if we look at two years period (and after bubble) Lyon G. (and whole NBIMiljenko Zuanic-10/23/2001
813And thanks to you Rick, NBIX is the lone Dec 2000 purchase that has actually worScott H. Davis-10/23/2001
812Two months left, but someone is really going to have to do tricks to beat out Lyscaram(o)uche-10/22/2001
811Monday October 22, 7:32 am Eastern Time Press Release SOURCE: Neurocrine BioscieMiljenko Zuanic-10/22/2001
810Thanks!! (eom)scaram(o)uche-10/12/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News